Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes

Journal of Clinical Investigation

Volumn 109, Issue 1, 2002, Pages 141-149

  Mauvais Jarvis, Franck ^a   Ueki, Kohjiro ^a   Fruman, David A ^a   Hirshman, Michael F ^a   Sakamoto, Kei ^a   Goodyear, Laurie J ^a   Iannacone, Matteo ^a   Accili, Domenico ^b   Cantley, Lewis C ^a   Ronald Kahn, C ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Columbia University ^*  (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVE SITE; GENE DELETION; GENE DISRUPTION; GENE TARGETING; GLUCOSE HOMEOSTASIS; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

EID: 0036142957     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213305     Document Type: Article

References (39)

1. Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes
2. Insulin action in the polycystic ovary syndrome
3. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling
4. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85a gene
5. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain
6. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85a gene
7. p85a gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-kinase), p50a, p55a, and p85a, with different PI 3-kinase activity elevating responses to insulin
8. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase
9. The role of phosphoinositide 3-kinase lipid products in cell function
10. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells
11. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
12. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin
13. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
14. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway
15. Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenol pyruvate carboxykinase gene transcription
16. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways
17. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats
18. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse
19. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase
20. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85a subunit of phosphoinositide 3-kinase
21. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85a
22. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85a
23. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: Stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit
24. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85a regulatory subunit
25. Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells
26. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
27. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
28. Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy
29. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
30. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
31. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
32. Diabetes. The missing link with obesity?
33. Positional cloning of the mouse obese gene and its human homologue
34. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
35. Regulation of the p85/p110alpha phosphatidylinositol 3′-kinase. Distinct roles for the nterminal and c-terminal SH2 domains
36. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival
37. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
38. Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin
39. Signaling pathways involved in the stimulation of glycogen synthesis by insulin in rat hepatocytes